U.S. Stem Cells Market Size & Outlook, 2025-2030

Name: U.S. Stem Cells Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The stem cells market in the United States is expected to reach a projected revenue of US$ 9,116.5 million by 2030. A compound annual growth rate of 9.5% is expected of the United States stem cells market from 2025 to 2030.

U.S. stem cells technology outlook (Revenue, USD million, 2018-2030)
- Expansion and Sub-Culture
- Cell Acquisition
  - Bone Marrow Harvest
  - Umbilical Blood Cord
  - Apheresis
- Cell Production
  - Therapeutic Cloning
  - In Vitro Fertilization
  - Cell Culture
  - Isolation
- Cryopreservation
U.S. stem cells therapy outlook (Revenue, USD million, 2018-2030)
- Allogenic
- Autologous
U.S. stem cells end use outlook (Revenue, USD million, 2018-2030)
- Pharmaceutical and Biotechnology Companies
- Hospitals & Cell Banks
- Academic & Research Institutes
U.S. stem cells product outlook (Revenue, USD million, 2018-2030)
- Adult Stem Cells
  - Mesenchymal Stem Cells
  - Hematopoietic Stem Cells (Blood Stem Cells)
  - Neural Stem Cells
  - Epithelial/Skin Stem Cells
  - Other Adult Stem Cells
- Human Embryonic Stem Cells
- Very Small Embryonic Like Stem Cells
- Induced Pluripotent Stem Cells
U.S. stem cells application outlook (Revenue, USD million, 2018-2030)
- Regenerative Medicine
  - Neurology
  - Oncology
  - Injuries
  - Incontinence
  - Hematology
  - Liver Disorder
  - Orthopedics
  - Cardiovascular and Myocardial Infraction
  - Diabetes
  - Others
- Drug Discovery and Development

U.S. Stem Cells Market Size & Outlook, 2025-2030

Sign up - it's easy, and free!